Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: LOVELACE BIOMEDICAL RESEARCH INSTITUTE
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-09-25 to 2026-05-24
Current total value of award: $4015506
Description: NON-CLINICAL SAFETY ASSESSMENT OF GENE THERAPY (PCCA, MMAB, DOK7 AND COLQ) TO SUPPORT PLATFORM GENE THERAPY FOR CONGENITAL MYASTHENIC DISEASES (DOK7, COLQ) AND ACIDEMIA (PCCA, MMAB)